MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback